Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Infinium Pharmachem Ltd.

NSE: INFINIUM | BSE:

₹221.30 -1.20 (-0.54%) 1D

Pharmaceuticals & Biotechnology

Buy Sell

Open an Account with Bigul in 5 minutes

Performance

Today’s low

218.00

Today’s High

228.00

52W low

130.00

52W High

315.70

Open Price

228.00

Prev. Close

220.0000

Volume

18500.00

Value

4094050.00

Fundamentals

Market Cap Cr

308.00

Price to Earnings

0.00

Price to Book Value

5.10

Dividend Yield

0.00

PE to Growth

0.00

Op Revenue TTM Cr

0.00

Net Profit TTM Cr

0.00

Cash From Operating Activity Cr

-13.04

Return on Equity %

19.22

EMA & SMA

Bullish Moving Averages

2

Bearish Moving Averages

14

5Day EMA

222.4

10Day EMA

222.6

12Day EMA

222.6

20Day EMA

222.4

26Day EMA

222.3

50Day EMA

222.9

100Day EMA

224.7

200Day EMA

216.8

5Day SMA

222.9

10Day SMA

222.1

20Day SMA

222.8

30Day SMA

222.1

50Day SMA

221.1

100Day SMA

226.4

150Day SMA

230.1

200Day SMA

237.6

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 Jul, 2024

43.2

Week

51.5

Month

59.3

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

222.43

PIVOT

First Resistance

226.87

Second Resistance

232.43

Third Resistance

236.87

First Support

216.87

Second Support

212.43

Third Support

206.87

Relative Strength Index

48.77

Money Flow Index

32.1

MACD

0.24

MACD Signal

0.33

Average True Range

10.48

Average Directional Index

18.96

Rate of Change (21)

-1.16

Rate of Change (125)

-6.62

Commodity Channel Index

-3.4

Williams %R

-44.1

BETA

1 Month

0.69

3 Month

0.59

1 Year

0.01

3 Year

PRICE CHANGE ANALYSIS

↓ -1.58%

1 Week

Low

High

218

231

↓ -1.16%

1 Month

Low

High

209

232

↑ 0.11%

3 Months

Low

High

209

264

↓ -4.2%

6 Months

Low

High

200

273

↑ 63.02%

1 Year

Low

High

130

315.7

Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 123.98 102.65 74.96 55.18 36.61
Operating Expenses Annual Cr 104.94 86.10 65.32 49.65 33.41
Operating Profit Annual 17.42 15.21 8.72 4.91 2.62
Operating Profit Margin Annual % 14.05 14.81 11.63 8.90 7.17
Total Expenses Annual Cr 109.12 90.38 67.56 51.42 35.22
EBIDT Annual Cr 19.04 16.55 9.64 5.53 3.20
EBIDT Annual margin % 15.36 16.12 12.87 10.03 8.74
Depreciation 2.41 1.29 0.58 0.65 0.58
PAT Before ExtraOrdinary Items Annual Cr 11.09 9.15 5.50 2.72 1.02
Net Profit Annual 11.09 9.15 5.50 2.72 1.02
Basic EPS Annual 7.97 18.00 54.13 26.75 10.01
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 57.75 21.70 12.55 7.05 4.32
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 5.50 7.63 13.62 5.79 5.66
Total Current Liabilities Annual Cr 14.49 31.09 22.88 17.97 10.61
Total Capital Plus Liabilities Annual Cr 77.74 60.42 49.06 30.81 20.58
Fixed Assets Annual 16.48 15.58 12.22 8.11 4.16
Total Non Current Assets Annual 17.51 16.41 15.12 8.50 4.53
Total Current Assets Annual 60.23 44.00 33.93 22.31 16.05
Total Assets Annual 77.74 60.42 49.06 30.81 20.58
Contingent Liabilities plus Commitments Annual Cr - 0.00 0.00 0.00 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual -14.97 7.35 9.14 6.82 2.32
Cash from Investing Activity Annual -3.29 -2.58 -7.17 -4.59 -1.08
Cash from Financing Annual Activity 23.19 -3.00 -1.66 -1.12 -1.23
Net Cash Flow Annual - 1.77 0.31 1.10 0.02
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 41.50 42.69 123.45 69.31 42.46
ROE Annual % 19.20 42.16 43.85 38.59 23.58
ROCE Annual % 26.29 52.03 34.62 38.02 26.24
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 15.56 16.33 13.02 10.14 8.87
Indicator Graph
Total Qtr Revenue cr
Operating Expenses Qtr
Operating Profit Qtr
EBIDT Qtr Cr
Depreciation Qtr
Net Profit Qtr
Basic EPS Qtr
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 137.20 115.58 100.05 71.15 39.42
Operating Expenses Annual Cr 117.13 98.18 89.09 65.58 36.36
Operating Profit Annual 18.53 16.05 10.03 4.95 2.48
Operating Profit Margin Annual % 13.50 13.88 10.03 6.96 6.30
Total Expenses Annual Cr 121.99 102.62 91.42 67.38 38.18
EBIDT Annual Cr 20.07 17.40 10.97 5.58 3.06
EBIDT Annual margin % 14.63 15.05 10.96 7.84 7.76
Depreciation 2.67 1.34 0.63 0.65 0.58
PAT Before ExtraOrdinary Items Annual Cr 11.50 9.82 6.69 2.73 0.87
Net Profit Annual 11.30 9.49 6.11 2.72 0.93
Basic EPS Annual 8.12 18.67 60.07 26.80 9.19
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 58.78 22.56 13.92 7.22 4.34
Minority Interest Liability Annual Cr 1.45 1.22 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 7.89 10.06 13.62 5.79 5.66
Total Current Liabilities Annual Cr 17.33 36.77 31.45 21.17 12.44
Total Capital Plus Liabilities Annual Cr 85.45 70.61 59.00 34.18 22.45
Fixed Assets Annual 19.65 18.81 12.68 8.58 4.16
Total Non Current Assets Annual 20.44 19.30 15.32 8.71 4.27
Total Current Assets Annual 65.01 51.31 43.68 25.47 18.17
Total Assets Annual 85.45 70.61 59.00 34.18 22.45
Contingent Liabilities plus Commitments Annual Cr - 0.00 0.00 0.00 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual -13.04 8.59 11.80 7.29 3.03
Cash from Investing Activity Annual -3.79 -4.96 -6.63 -5.00 -1.05
Cash from Financing Annual Activity 22.77 -3.10 -1.70 -1.16 -1.24
Net Cash Flow Annual - 0.53 3.46 1.13 0.74
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 43.28 46.79 136.94 70.98 42.70
ROE Annual % 19.22 42.06 43.86 37.75 21.51
ROCE Annual % 25.54 47.44 37.51 37.85 24.76
Total Debt to Total Equity Annual 0.00 0.00 0.00 0.00 0.00
EBDIT Annual Margin % 14.79 15.23 11.06 7.90 7.87
Name Holding Percent Holding Id Pledged % Locked %
Name Holding Percent Holding Id Pledged % Locked %
PRAVIN BHADABHAI MADHANI 13.67 75290126 0 100
SANJAYKUMAR VITHTHALBHAI PATEL 11.48 75290125 0 100
BHADABHAI KACHARABHAI MADHANI 10.73 75290132 0 100
LAVJIBHAI RAMJIBHAI CHIKHALIYA 8.51 75290120 0 100
VARSHABEN PRAVINBHAI MADHANI 8.23 75290131 0 100
MITESH LAVJIBHAI CHIKHALIYA 5.35 75290124 0 100
DAXA SANJAYKUMAR PATEL 4.12 75290134 0 100
BHARAT KHODABHAI MADHANI 3.9 75290128 0 100
SHARDABEN LAVJIBHAI CHIKHALIYA 2.24 75290122 0 100
MIGNESH LAVJIBHAI CHIKHALIYA 1.63 75290129 0 100
PIYUSH VITHTHALBHAI CHIKHALIYA 0.9 75290123 0 100
URVISHABEN PIYUSHBHAI CHIKHALIYA 0.81 75290130 0 100
Name Holding Percent Holding Id
Name Holding Percent Holding Id
DIPEN BABULAL DOBARIYA 2.14 75290139
VINITKUMAR MAHESHKUMAR DOBARIYA 2.06 75290141
PATEL BHUPESH VAHALABHAI 1.02 75290140
HUF 1.57 75290146
Clearing member 1.28 75290145
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 29, 2024 Audited Results -
Oct 27, 2023 Quarterly Results -
Aug 02, 2023 Bonus issue -
May 17, 2023 Audited Results -
Ex-Date Bonus Ratio Record Date
Sep 13, 2023 1:1 2023-09-13

FAQs

The latest market price of Infinium Pharmachem Ltd. on NSE was Rs. 221.30 as of today.

The opening share price of Infinium Pharmachem Ltd. was Rs. 228.00 as of today.

The 52-week high share price of Infinium Pharmachem Ltd. was Rs. 315.70.

The 52 week low share price of Infinium Pharmachem Ltd. was Rs. 130.00.

Infinium Pharmachem Ltd. has a market cap of Rs. 308.00 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Infinium Pharmachem Ltd. is 0.00. Please refer to the Fundamentals section for further details.

The operating revenue for Infinium Pharmachem Ltd. in the last FY was Rs.  0.00 crore. Please refer to the Financials section for further details.

The Net Profit for Infinium Pharmachem Ltd. in the last FY was Rs. 0.00 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please find Corporate actions section for more details.

The latest bonus issue declared by Infinium Pharmachem Ltd. was as of 2023-09-13. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Infinium Pharmachem Ltd..

Close

Let's Open Free Demat Account